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Abstract
Melatonin is secreted principally by the pineal gland and mainly at nighttime. The primary physiological
function is to convey information of the daily cycle of light and darkness to the body. In addition, it may
have other health-related functions. Melatonin is synthesized from tryptophan, an essential dietary amino
acid. It has been demonstrated that some nutritional factors, such as intake of vegetables, caffeine, and
some vitamins and minerals, could modify melatonin production but with less intensity than light, the
most dominant synchronizer of melatonin production. This review will focus on the nutritional factors
apart from the intake of tryptophan that affect melatonin levels in humans. Overall, foods containing
melatonin or promoting the synthesis of it by impacting the availability of tryptophan, as well those
containing vitamins and minerals which are needed as co-factors and activators in the synthesis of
melatonin, may modulate the levels of melatonin. Even so, the influence of daytime diet on the synthesis of
nocturnal melatonin is limited, however, the influence of the diet seems to be more obvious on the daytime
levels.
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M
any normal physiological functions occur at
specific times of the day. These biological
rhythms, called circadian rhythms, are con-
trolled by an endogenous time-keeping system oscillating
approximately 24-h cycle under constant conditions
(1, 2). The master oscillator, which responds to interior
and exterior signals, is located in the suprachiasmatic
nucleus (SCN) of the anterior hypothalamus in the
brain. The most powerful pacemaker is the environmen-
tal lightdark cycle. SCN neurons transmit this rhythmic
lightdark information to other brain regions and
peripheral organs that control many aspects of physiol-
ogy and behavior, including sleepwake cycles, cardio-
vascular activity, the endocrine system, dietary behavior
and energy metabolism. These signals are distributed
via two main pathways: the direct pathway, which uses
the autonomous nervous system and the indirect path-
way, which operates via hormonal signals controlled
by the SCN, such as the nocturnal peaking secretion
of pineal melatonin or the daily increase in adrenal
glucocorticoids (3).
Disruption of the circadian rhythm and sleepwake
cycles are considered risk factors for a variety of health
problems including obesity and cardiovascular disease
(3, 4). Several preclinical studies have identified dietary
components, such as glucose (5, 6), sodium (7), ethanol
(8), or caffeine (9) being capable of phase-shifting
circadian rhythms by modifying the expression of genetic
components of the biological clock, i.e. clock genes.
Changes in the circadian cycle modify metabolism, but
in addition, alterations in metabolism are also able to
entrain physiological clocks, resulting in changes to the
rhythms as outlined previously (1, 4).
One possible mechanism by which diet can influence
circadian rhythms is by modifying the secretion of
melatonin. Melatonin is a circulating neurohormone
secreted predominantly at night. It is important in
conveying the daily cycle of light and darkness to the
body, thus regulating circadian rhythms and helping us to
fall and stay asleep. In addition to its’ regulatory role,
melatonin has antioxidative capacity, immunomodula-
tory potency, and also appears to be protective against
a variety of cancers, especially breast cancer, although
data is based mostly on observational studies and
animal models (1012). Exogenous melatonin has been
used for the treatment of sleep disorders of circadian
origin such as jet lag and delayed sleep phase syndrome
and as complement of other therapeutic drugs for the
treatment of numerous diseases including glaucoma,
irritable bowel disease, and certain types of cancers
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mainly to either enhance the therapeutic effect of
conventional drug therapy or to reduce their toxicity
thus ameliorating the side-effects (1318). Negative
side-effects of exogenous melatonin in abovementioned
clinical trials are rare.
The regulating system for the secretion of melatonin
is complex. Light is the most influential environmental
factor. In addition, melatonin synthesis depends upon
availability of its precursor, tryptophan (TRP), which
is an essential amino acid and is thus an essential
component of the diet. If intake of TRP is severely
restricted, synthesis of melatonin is significantly
reduced in humans (19). Few studies have explored the
influence of other dietary factors on the fluctuation of
melatonin levels, for example the intake of certain food
items or the availability of nutrients. This narrative review
will focus on the nutritional factors apart from the intake
of TRP that affect melatonin levels in humans. We used
the electronic bibliographical database PubMed until
April 2012 (without any methodological restrictions), to
identify studies using the following keywords: melatonin,
6-sulphatoxymelatonin, diet, vegetable, alcohol, and B
vitamins. In addition, we reviewed the references of
identified studies and of selected narrative review articles.
Synthesis of melatonin
The synthesis and physiological function of melatonin
have been recently described accurately in several
review articles and are here only very briefly summarized
(10, 2025).
Melatonin is a neurotransmitter secreted predomi-
nantly by the pineal gland. There are extra-pineal sites
of melatonin production, such as the retina and the gut.
Even if the synthesis of melatonin in these extra-pineal
sites contribute to the total concentration of melatonin,
the physiological significance of these sites is uncertain.
Melatonin is synthesized from its precursor, the essential
amino acid TRP (Fig. 1). The rate of melatonin formation
depends on the activity of enzymes  arylalkylamine-
N-acetyltransferase (AANAT) and to a lesser extent,
tryptophan hydroxylase (TPH). AANAT is represented
mostly in the pineal gland where its activity is controlled by
SCN. Activity of pineal TPH fluctuates in a clock-driven
circadian rhythm, which reaches its highest levels during
the night.
Melatonin synthesis is controlled by both an endogen-
ous circadian clock and by environmental light. Light is
the dominant environmental factor that controls its
synthesis. Pineal melatonin levels begin increasing in the
Fig. 1. The synthetic pathway and metabolism of melatonin and possible sites for some nutrients to influence on the
synthesis. Enzymes are in underlined capital letters in italics. TRP, tryptophan; TPH, tryptophan hydroxylase; TDO,
tryptophan dioxygenase; AADC, aromatic aminoacid decarboxylase; AANAT, arylalkylamone-N-acetyltransferase; HIOMT,
hydroxyindole-O-methyltransferase; 6-SMT, 6-sulphatoxymelatonin; SAMe, S-adenosylmethionine.
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late evening, reaching the maximum in the early hours
between 2:00 and 4:00 a.m., followed by a slow decline to
lower daytime levels. Daytime levels of melatonin are
barely detectable. In addition to sunlight, artificial indoor
lighting can be bright enough to prevent the nocturnal
release of melatonin.
Normal production of melatonin can vary considerably
between individuals. In general, melatonin production
decrease with aging. Among the other factors that have
been most consistently linked to modified melatonin
levels are disrupted lightdark cycles, night work and
being overweight. In addition, it has been demonstrated
that some nutritional factors could also modify melato-
nin production, however less intensely. Weather dietary
factors contribute only to the pineal production of
melatonin or also to the extra-pineal sites such as the
gastrointestinal production is not known.
Once synthesized, melatonin is not stored in producing
cells, but is quickly released into the blood and begins
circulation. Thus, the concentration in plasma faithfully
reflects pineal secretion. In addition melatonin concen-
tration can be measured in other body fluids as saliva and
urine. Saliva levels are about 40% of those in plasma.
Endogenous nocturnal melatonin production has been
estimated to be about 1080 mg per night, the daytime
production being significantly less.
The metabolism of melatonin is rapid, and its half-life
in humans varies between 10 and 60 min following
exogenous administration. It is deactivated mostly by
the liver and excreted in urine. Urinary metabolite,
6-sulphatoxymelatonin (6-SMT) reflects the plasma mel-
atonin profile and can be used for evaluation of
melatonin status. In urine, 5080% of 6-SMT appears in
the overnight sample.
Dietary compounds
There are several studies indicating dietary influence on
the synthesis or the concentration of melatonin.
Energy restriction
Strong influence of food on melatonin synthesis is
detected in studies of subjects undergoing periods of
fasting. Energy restriction reduces the nocturnal secretion
of melatonin although the number of human studies
proving this is limited. Short-term voluntary fasting by
total rejection of food or with very limited intake of
energy (B300 kcal per day) from 2 to 7 days reduces
melatonin concentration in the blood by about 20%
(2628). In these studies, however, no changes were
noticed in the excreted metabolites of melatonin in urine.
Glucose supplementation during short-term fasting re-
turns the decreased melatonin concentration to normal,
suggesting that human pinealocytes, or other producing
cells, require a certain minimal amount of glucose
delivery to function normally (27, 28).
Edible plants and plant-based products
Some food items, especially edible plants, contain mela-
tonin and its precursor TRP as well. Actually, the
presence of melatonin in plants is universal, although
with widely varied concentrations from picograms to
micrograms per gram of plant tissue (29). Melatonin
has been detected in notable amounts for example in
tomatoes, olives, barley, rice and walnuts (Table 1)
(2940). Recent studies have uncovered that melatonin
concentrations differ not only among plant species, but
also within varieties of the same species. In grapes, for
example, cultivars Nebbiolo and Croatina have very
high melatonin levels, about 0.80.9 ng/g, whereas
Cabernet franc contains only 0.005 ng/g. Thus, in a glass
of wine, the concentration of melatonin may vary
considerably, from picograms to many nanograms per
milliliter (41, 42).
The bioavailability of plant-based melatonin has been
demonstrated mainly in animals but also in humans (30,
35, 43). It has been measured as increased blood
concentration or heightened amounts of excreted urinary
6-SMT after the ingestion of melatonin-containing pro-
ducts, such as vegetables or barley-based beer (43, 44).
Even some dose dependency has been noticed  the mean
urinary 6-SMT was 16% higher in Japanese women
within the highest quartile of vegetable intake compared
to those with the lowest intake (45). However, vegetables
and grain products contain large amounts of vitamins
and minerals. Thus, even if increased levels of melatonin
have been noticed in these studies, it cannot be excluded
that the increase is due to boosted endogenous melatonin
synthesis by the possible stimulatory effect of ingested
products instead of absorbed dietary melatonin only.
In addition to wine, remarkably high melatonin con-
centrations have been detected in coffee beans as was
outlined previously (29, 35). Although a cup of coffee is
estimated to contain even as much as 40 mg of melatonin,
corresponding the nocturnal endogenous production, the
general effect in the circulating melatonin concentration
may differ, since coffee contains caffeine which may
Table 1. Some examples of melatonin content in plants and foods
measured by immunological and chromatographic techniques
Plant/food Melatonin Reference
Tomato 3114 ng/g 32, 37
Walnuts 34 ng/g 30
Cereals (rice, barley) 3001,000 pg/g 39
Strawberry 111 ng/g 32
Olive oil 53119 pg/ml 34
Wine 50230 pg/ml 32, 36
Beer 52170 pg/ml 43
Cow’s milk (unprocessed) 325 pg/ml 38, 40
Nighttime milk 1040 ng/ml 62
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reduce endogenous nocturnal melatonin levels. Results in
clinical studies are conflicting. In two short-term studies,
a single dose of 200 mg caffeine capsules decreased
nighttime melatonin secretion, whereas a significant
increase of 32% was observed in another study (4648).
In still another study, subjects were administered repeated
400 mg doses of caffeine capsules at 1-week intervals.
Analysis yielded a slight trend of 7% reduction of
nighttime melatonin levels in healthy young adults (49).
When caffeine was administered to study subjects via
coffee, reduction of more than 50% was found in night-
time 6-SMT excretion compared with decaffeinated coffee
in another small study (50).
Caffeine has both the stimulatory and inhibitory
mechanisms affecting the levels of melatonin. Which of
these dominate in normal healthy subjects is not clear
since hypothesis of mechanisms have been tested mostly
in vitro and by using animal models. Caffeine may alter
the expression level of clock genes either up-regulating
or down-regulating clock gene amplitudes (51, 52).
Caffeine acts as an adenosine receptor antagonist.
Adenosine increases intracellular cAMP levels via ade-
nosine receptor, which increases the production of
AANAT, the rate limiting enzyme in melatonin synthesis
(53). Thus as adeosine receptors are blocked by caffeine,
the synthesis of melatonin decreases. In addition
caffeine may also reduce the break-down of melatonin.
Caffeine and melatonin compete for the same metaboliz-
ing liver cytochrome P450 enzymes, resulting in higher
serum levels of melatonin after large doses of caffeine
(48, 54).
There are significant differences in before mentioned
studies in their designs, in timing and dosing of caffeine
as well as sampling and analyzing melatonin and its
metabolite. In addition, subjects were either sleep-
deprived or not, which greatly modify synthesis of
melatonin and can at least partly explain the differences.
If study subjects include both males and females, it may
also have an influence on the results, since menstruation
has been reported to modify such levels, while oral
contraceptives have been found to increase nighttime
melatonin levels due to inhibiting catalyzing enzymes in
the liver (5558).
Nighttime milk
Melatonin is a natural compound found in milk. Con-
centration of melatonin exhibits a marked daily rhythm,
with increasing concentrations in milk produced at night
(40, 59). This phenomenon seems to be universal
amongst mammals.
Since milk is the primary component of an infant’s
diet, and nighttime lactation confirms the nutritional
adequacy, melatonin content of nighttime milk may have
further physiological relevance. This theory may benefit
from further study, but it seems plausible that maternal
melatonin may pass through milk to the infant resulting
in improved nocturnal sleep, although this is based on a
very limited number of observations (59). In addition,
if TRP-enriched commercial infant milk formula is
served at night, improvements in sleep parameters
and increased urinary metabolites of serotonin were
observed, suggesting increased use of serotonin to
produce melatonin (60, 61).
Studies showing the influence of the melatonin content
of cow’s milk on the fluctuation of melatonin levels in
adults are even scarcer. In institutionalized elderly sub-
jects, commercial milk was replaced with melatonin-rich
nighttime milk in a double-blind study (62). The ingested
total amount of 1020 ng melatonin from nighttime milk
is, however, such a small dose divided into several meals,
that physiological significance of it is hard to understand.
Morning activity of subjects, however, was significantly
increased, indicating some difference between normal
commercial milk and nighttime milk, of which the
content of melatonin is most obvious.
Alcohol
Conclusions regarding the influence of alcohol on
melatonin levels have been found to be inconsistent.
Both acute and chronic consumption of alcohol at a level
corresponding to ‘social drinking’ (10100 g of ethanol
per day) reduce melatonin levels in the blood and in the
saliva in three small studies of healthy volunteers (6365),
but not in a fourth study (66). In addition to absolute
amount of ethanol, other properties of alcoholic beve-
rages may also have an influence on the overall effect.
As mentioned above, wine and beer contain melatonin,
and consequently may have additional influence on
detectable melatonin levels in the body. In a study of
strong beer (alcoholic content of 7.2%), 45 min after a
single dose of 330 ml for women and 660 ml for men,
corresponding doses of 2448 g of ethanol, melatonin
level in serum was significantly elevated in a small study
with seven healthy subjects (43). This increase was
explained by the researchers by the melatonin content
of beer.
The influence of alcohol on urinary metabolites of
melatonin, however, conflicts with these findings. Even if
single or repeated doses of alcohol in the evening reduces
the nocturnal melatonin secretion to the blood dose-
dependently, no corresponding changes in 912 h urinary
excretion of melatonin metabolites were noticed (63, 64,
67). In these studies healthy participants  males and
females  received doses varying from 15120 g ethanol
per day either as single or repeated daily doses. However,
in a large study with over 200 healthy women between the
ages of 20 and 74, it was found that the nocturnal urinary
concentration of the 6-SMT decreased dose-dependently
with increasing consumption of alcoholic beverages in
the preceding 24-h period (68). A categorical analysis
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revealed no effect of one drink (on over 70% of observed
days), but a 9% reduction with two drinks, a 15%
reduction with three drinks, and a 17% reduction with
four or more drinks (on only 2% of observed days). This
was shown also after taking into account the effects of
age, number of daily hours of darkness, use of medica-
tions that affect melatonin levels and body mass index.
Thus, alcohol consumption seems to reduce the
melatonin concentration in the blood, but whether there
is an association between urinary melatonin metabolites
and alcohol is not as clear, perhaps due to varied
beverages and doses used and differences in methods
for urine collection as well as ethanol-based metabolic
differences. Several possibilities have been hypothesized
to explain how ethanol inhibits melatonin secretion.
Hypotheses vary from disturbed sleep patterns and loss
of daily rhythm caused by alcohol use to reduced TPH
activity to phase delay in AANAT gene expression and
activity to disturbed steps in the synthesis or excretion of
melatonin (64, 69). In addition, ethanol decreases TRP
levels in plasma resulting in a short-term decrease in the
availability of TRP. A small amount of glucose is needed
in the synthesis of melatonin. Since ethanol has proper-
ties that decrease blood-glucose levels, it has been
speculated that an insufficient amount of glucose in
pinealocytes would explain the reduced levels of melato-
nin. The mechanisms behind these remain to be studied
further.
Availability of nutrients
Evidence of nutrients’ influence on melatonin synthesis
tends to vary. There are some studies, based mostly on
animal evidence, which prove the importance of B
vitamins, magnesium, zinc and polyunsaturated fatty
acids.
Folate, magnesium and zinc deficiencies have been
linked with lower melatonin levels in rodents and in one
rodent study, vitamin B6, either alone or in combination
with zinc, increased plasma melatonin (7073). Folate
and B6 vitamin are supposed to boost the formation of
serotonin from TRP as coenzymes. Zinc and magnesium,
instead, are supposed to enhance the formation of
melatonin from serotonin by binding to AANAT enzyme,
thus activating it and increasing the affinity of serotonin
for binding to AANAT (74, 75). In humans, the role of
these vitamins and minerals is less well studied in this
connection.
In a large study of nearly 300 Japanese women, folate
intake was not connected with urinary excretion of 6-
SMT levels (45). Urinary 6-SMT, however, associated
positively clearly with intake of all vegetables and
especially with green and yellow vegetables. In a Nurses’
Health Study of about 1,000 US women, no association
was found between the high intake of various nutrients,
such as folate, vitamin B6 and zinc and increased urinary
melatonin excretion (76). Besides marginal positive
associations between orange juice, tomato and dairy
cream consumption and urinary 6-SMT, only meat
consumption was significantly and inversely associated
with urinary 6-SMT in this large study. Neither of these
studies, however, reported the vitamin status of the
subjects, only their calculated dietary intake.
In a small study of 12 healthy men, orally-supplemented
pyridoxine (one vitamers of vitamin B6) as a dose
of 100 mg in the evening hours had no effect on nocturnal
melatonin levels in the blood (77). Nocturnal melatonin
levels in the blood, however, doubled in over 100 small
children between the ages of 18 months and 8 years
when pyridoxine was administered at night intrave-
nously at doses of 3 mg/kg (78). Any possible deficiency
of pyridoxine in these hospitalized children was not
reported.
Reliable clinical evidence of boosted melatonin secre-
tion following the ingestion of cations, magnesium or
zinc, does not yet exist. In a study of 10 healthy men, a
single intravenous dose of magnesium sulphate was found
to have no effect on the release of melatonin (79).
No correlation, however, between serum magnesium
and melatonin levels was found in patients with inter-
vertebral disc herniation. Instead, a clear positive
correlation between serum zinc and melatonin level was
found (80).
The pineal gland contains high levels of n-6 and n-3
polyunsaturated fatty acids (PUFA), especially arachido-
nic acid and docosahexaenoic acid (DHA) (81). There is
some evidence that fatty acid status can influence
melatonin synthesis. In rodents, an n-3 deficient diet
reduces nighttime melatonin secretion, which returns to
normal with supplemented DHA (82, 83). Based on
animal experiments, the rhythm of AANAT activity may
be altered by n-3 status and n-3/n-6 ratio, as well as these
may modify the activities of membrane-bound proteins
including enzymes, receptors and transporter proteins
(81).
We did not find any similar PUFA studies with
humans. The only clinical study to measure the impor-
tance of dietary PUFA on melatonin levels in humans as
yet found is a study of insomnia patients (84). Subjects
ingested dietary supplements in capsule form containing
soy oil, cade oil, humulus lupus extract and soy lecithin
daily for a month immediately before sleep. Neither this
supplement nor placebo capsules containing olive oil had
any influence on urinary excretion of 6-SMT (84).
Clinical relevance and conclusions
Melatonin secretion is strongly related to the duration of
darkness. Its most definitive physiological role is to
convey information to the body about day length for a
variety of physiological functions. In addition to melato-
nin’s role as an endogenous synchronizer, growing
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evidence suggests its anti-oxidative activity as well as
its having a role in modulating immune responses.
At present, a growing interest is focused on the validity
of the anti-tumor mechanisms of melatonin.
Synthesis of melatonin requires tryptophan as a
precursor as well as a smoothly functioning cascade of
several enzyme-based reactions, first to compose seroto-
nin and subsequently melatonin. Several vitamins and
minerals act as co-factors and activators in these
processes, thus a clear deficiency of needed nutrients
may restrict the synthesis. Severe deficiencies, however,
are rare in western countries apart from some subgroups.
In addition, fluctuating melatonin levels can be boosted
by ingesting products containing melatonin. The bioa-
vailability of plant-based melatonin is evident, at least in
rodents, and could explain some health benefits of
vegetables, fruits and grain products.
Diet and nutrients modulate fluctuating melatonin
levels, but the influence is minor if compared with the
power of the lightdark cycle. Other health-related life-
style factors such as body weight, which is connected to
diet, may have as much effect on melatonin levels as
specific dietary choices. Thus, the health benefits of diet-
driven melatonin boosts seem not to be the product of
any single food or nutrients present in the diet. In general,
diets rich in vegetables, fruits and grain products contain
considerable levels of dietary melatonin. Vitamins and
minerals contribute to the synthesis of endogenous
melatonin while the body is active. Even so, the influence
of daytime diet on the synthesis of nocturnal melatonin is
very limited, however, the influence of diet seems to be
more obvious on the daytime levels of melatonin.
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